Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
Hemab raised $157m Series C led by Sofinnova, joined by Avoro Capital, RA Capital, Novo, Access Biotechnology, Deep Track, HealthCap, Invus, Maj Invest

Hemab raised $157m Series C led by Sofinnova, joined by Avoro Capital, RA Capital, Novo, Access Biotechnology, Deep Track, HealthCap, Invus, Maj Invest

Biotech Health services

Denmark

Sweden

France

United States

Investments

16 October 2025

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

Hemab (company)

Denmark

Biotech Health services

Total investments received (USD): 347M

Round value (USD): 157M

Round investors: HealthCap Novo A/S Sofinnova Partners Deep Track Capital Access Biotechnology Maj Invest RA Capital Management Avoro Capital Invus

Company: Hemab

Industry: Biotech Health services

Related deals

Sidera Bio secures DKK 700 million in a Series A biotech round with Novo Holdings, Forbion, RA Capital Healthcare Fund LP, and Gilde Healthcare.

Biotech Health services

Denmark

Netherlands

United States

Investments 19 November 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2025. Made with in Stockholm

Top